Octapharma USA research at AAAAI: cutaquig® study at higher infusion rates presented
PARAMUS, N.J. (March 6, 2023) – Octapharma USA presented research at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting evaluating the efficacy...